FGFR1 and squamous cell lung carcinoma: To squamous cell lung cancer, the FGFR1 amplification is an independent adverse prognostic marker in early stage patients [32], and another study found that no significant difference in OS by FGFR1 amplification status in advanced stage subset [31].